EXPRESSION OF METALLOPROTEINASE 2 AND 9 AND THEIR INHIBITORS IN RENAL CELL CARCINOMA
- 1 November 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (5), 1914-1918
- https://doi.org/10.1016/s0022-5347(01)62443-1
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Analysis of MT1-MMP and MMP2 expression in human gastric cancersInternational Journal of Cancer, 1997
- Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinomaCancer, 1996
- MATRIX METALLOPROTEINASE-2 (72 kD TYPE IV COLLAGENASE) EXPRESSION OCCURS IN THE EARLY STAGE OF HUMAN MELANOCYTIC TUMOUR PROGRESSION AND MAY HAVE PROGNOSTIC VALUEThe Journal of Pathology, 1996
- Characterization of Gelatinases Linked to Extracellular Matrix Invasion in Ovarian Adenocarcinoma: Purification of Matrix Metalloproteinase 2Gynecologic Oncology, 1996
- Analysis of Expression of Matrix Metalloproteinases-2 and −9 in Hypopharyngeal Squamous Cell Carcinoma by in Situ HybridizationAnnals of Otology, Rhinology & Laryngology, 1995
- Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasiaBritish Journal of Cancer, 1994
- Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factorBritish Journal of Cancer, 1993
- Expression of Matrix Metalloproteinase-2 Related to Lymph Node Metastasis of Oral Squamous Cell Carcinoma: A Clinicopathologic StudyAmerican Journal of Clinical Pathology, 1993
- Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: Not an invariant correlation with metastasisInternational Journal of Cancer, 1992